Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource | 
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | benzthiazide | 456255 | drug-path | 
| ECM-receptor interaction | R-HSA-373711 | map04512 | benzthiazide | 456255 | drug-path | 
| Allograft rejection | R-HSA-9679028 | map05330 | benzthiazide | 456255 | drug-path | 
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | benzthiazide | 456255 | drug-path | 
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | benzthiazide | 456255 | drug-path | 
| Olfactory transduction | R-HSA-9751605 | map04740 | benzthiazide | 456255 | drug-path | 
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | benzthiazide | 456255 | drug-path | 
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | cefsulodin | 6915744 | drug-path | 
| Alzheimer's disease | R-HSA-1643685 | 0 | cefsulodin | 6915744 | drug-path | 
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cefsulodin | 6915744 | drug-path | 
| Olfactory transduction | R-HSA-9751605 | map04740 | cefsulodin | 6915744 | drug-path | 
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefsulodin | 6915744 | drug-path | 
| Asthma | R-HSA-444620 | map05310 | cefsulodin | 6915744 | drug-path | 
| Allograft rejection | R-HSA-9679028 | map05330 | cefsulodin | 6915744 | drug-path | 
| Homologous recombination | R-HSA-5685942 | map03440 | cefsulodin | 6915744 | drug-path | 
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cefsulodin | 6915744 | drug-path | 
| Apoptosis | R-HSA-109581 | map04210 | cefsulodin | 6915744 | drug-path | 
| Basal transcription factors | R-HSA-3232118 | map03022 | cefsulodin | 6915744 | drug-path | 
| Olfactory transduction | R-HSA-9751605 | map04740 | spectinomycin | 2343 | drug-path | 
| Renal cell carcinoma | R-HSA-9794523 | map05211 | spectinomycin | 2343 | drug-path |